Large study monitors safety of common sedative
NCT ID NCT05254366
Summary
This study aimed to observe the safety of the sedative drug remazolam in real-world medical practice. It followed 2000 patients in China who received the drug for sedation during painless stomach and colon examinations. The main goal was to collect information on any side effects or problems that occurred.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROSCOPIC AND COLONOSCOPIC SEDATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430021, China
Conditions
Explore the condition pages connected to this study.